Does chronic hyperglycemia worsen cognitive function through cerebral microvascular injury?

Chronic hyperglycemia has a biologically coherent and clinically relevant pathway to cerebral small-vessel injury and cognitive decline. The strongest human longitudinal evidence concerns the final link: MRI evidence of small-vessel disease predicts later cognitive deterioration, particularly in executive function and attention.

Hyperglycemia, oxidative stress, and endothelial injury

• Excess glucose promotes reactive-oxygen-species production through mitochondrial superoxide generation, AGE–RAGE/NADPH-oxidase signaling, polyol-pathway NADPH depletion, and DAG–PKC activation. These pathways reduce nitric-oxide (NO) availability and promote endothelial inflammation and dysfunction.
• Cerebral relevance is supported experimentally: AGE exposure in brain microvascular endothelial cells produces sustained oxidative stress and increased permeability. In a human triple-cell blood–brain-barrier model, high glucose reduced electrical resistance, increased tracer flux, and disrupted the tight-junction protein ZO-1.
• Human vascular findings are directionally consistent but not definitive. In treated type 2 diabetes, flow-mediated dilation was poorer at HbA1c ≥8% than at intermediate HbA1c levels, although diabetes duration and correlated vascular risk factors also appear influential.

Cerebral microvascular mechanisms

• ROS can form peroxynitrite, uncouple eNOS, and further reduce NO-mediated vasodilation. Resulting impaired vasoreactivity, hypoperfusion, endothelial injury, and blood–brain-barrier leakage provide plausible routes to white-matter injury.
• In partial eNOS-deficient mice, early hypoperfusion and barrier leakage preceded oxidative stress and white-matter pathology; nitrate prevented these changes. Barrier leakage may also permit plasma proteins and inflammatory mediators into brain tissue, amplifying vascular injury.

Cognitive implications

• A 2024 meta-analysis of 23 prospective studies (11,486 initially cognitively unimpaired older adults) linked small-vessel-disease MRI markers to subsequent decline in global cognition, executive function, memory, and attention.
• White-matter hyperintensities have also been associated with incident dementia (pooled risk 1.9; 95% CI 1.3–2.8).

Bottom line

• The claim is supported: chronic hyperglycemia can plausibly drive oxidative and endothelial injury that damages cerebral microvessels, while cerebral small-vessel injury is a strong predictor of later cognitive worsening. For a 77-year-old, overall vascular risk and MRI findings should be interpreted alongside cognitive trajectory and other contributors to cognitive impairment.